Package 72189-595-60

Brand: oxaprozin

Generic: oxaprozin
NDC Package

Package Facts

Identity

Package NDC 72189-595-60
Digits Only 7218959560
Product NDC 72189-595
Description

60 TABLET, FILM COATED in 1 BOTTLE (72189-595-60)

Marketing

Marketing Status
Marketed Since 2024-12-02
Brand oxaprozin
Generic oxaprozin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "284ce161-0a4b-8999-e063-6394a90aa60a", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["MHJ80W9LRB"], "rxcui": ["312132"], "spl_set_id": ["284ce161-0a4a-8999-e063-6394a90aa60a"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Direct_Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (72189-595-60)", "package_ndc": "72189-595-60", "marketing_start_date": "20241202"}], "brand_name": "Oxaprozin", "product_id": "72189-595_284ce161-0a4b-8999-e063-6394a90aa60a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "72189-595", "generic_name": "Oxaprozin", "labeler_name": "Direct_Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxaprozin", "active_ingredients": [{"name": "OXAPROZIN", "strength": "600 mg/1"}], "application_number": "ANDA075855", "marketing_category": "ANDA", "marketing_start_date": "20241202", "listing_expiration_date": "20261231"}